Health-care administrations require that the health-care interventions that are included in the portfolio of services of the Public Health System should have demonstrable socioeconomic added value as well as therapeutic utility. PORIB concentrates on:

• Preparing dossiers and clinical-economic evaluation reports for National and Regional Health Authorities (development of strategies for negotiation of pricing and reimbursement), health technology assessment agencies, pharmacy and therapeutics, and new medicines commissions.
• Designing Marketing strategies for new products using economic variables. Development plans of economic evaluation and health outcomes research.
• Product-launch consulting
• Developing interactive models (complemented by reports on scenarios) for the direct use for Product Specialists, Medical Affairs or Medical Marketing and Key Account Managers in order to demonstrate the value of health-care intervention to the decision makers. Interactive models need to have, as fundamental characteristics, adaptability and flexibility in the interpreting results under different scenarios.
• Benchmarking programs.